Covered recipient · General Payments record
FREDERICK BOLTZ
General Payments · PY2018–2024
$7,729.99
- Reported across 434 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $856.83 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $192.88 | 8 |
| EMD Serono, Inc. | $151.99 | 2 |
| EISAI INC. | $115.51 | 1 |
| CSL Behring | $59.57 | 2 |
| PFIZER INC. | $57.21 | 3 |
| Lilly USA, LLC | $40.36 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.07 | 1 |
| Ceribell, Inc. | $25.00 | 1 |
| UCB, Inc. | $23.07 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.82 | 1 |
| Neurocrine BioSciences, Inc. | $22.56 | 1 |
| MDD US Operations, LLC | $22.40 | 1 |
| ACADIA Pharmaceuticals Inc | $22.32 | 1 |
| Vanda Pharmaceuticals Inc. | $21.17 | 1 |
| Abbott Laboratories | $20.46 | 1 |
| Celgene Corporation | $17.78 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.46 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125372016 | CMS |
| ABBVIE INC. | $24.42 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345022 | CMS |
| ABBVIE INC. | $33.41 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345024 | CMS |
| ABBVIE INC. | $8.66 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345026 | CMS |
| ABBVIE INC. | $31.92 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345028 | CMS |
| ABBVIE INC. | $16.31 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345030 | CMS |
| ABBVIE INC. | $13.13 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345032 | CMS |
| ABBVIE INC. | $33.74 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345034 | CMS |
| ABBVIE INC. | $31.29 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345036 | CMS |
| ACADIA Pharmaceuticals Inc | $22.32 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147964107 | CMS |
| Alexion Pharmaceuticals, Inc. | $22.82 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110537002 | CMS |
| Celgene Corporation | $17.78 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101105094 | CMS |
| Ceribell, Inc. | $25.00 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153952814 | CMS |
| CSL Behring | $29.37 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134655041 | CMS |
| CSL Behring | $30.20 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134655077 | CMS |
| Eisai Inc. | $115.51 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110745968 | CMS |
| EMD Serono, Inc. | $24.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120271438 | CMS |
| EMD Serono, Inc. | $127.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120279376 | CMS |
| Lilly USA, LLC | $21.32 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134998794 | CMS |
| Lilly USA, LLC | $19.04 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134992080 | CMS |
| MDD US Operations, LLC | $22.40 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147751100 | CMS |
| Neurocrine Biosciences, Inc. | $22.56 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150848382 | CMS |
| Novartis Pharmaceuticals Corporation | $14.66 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086678189 | CMS |
| PFIZER INC. | $13.83 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131142894 | CMS |
| PFIZER INC. | $28.53 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131880581 | CMS |
| PFIZER INC. | $14.85 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131194691 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.07 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137492591 | CMS |
| UCB, Inc. | $23.07 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143065395 | CMS |
| Vanda Pharmaceuticals Inc. | $21.17 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133897299 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.